Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000589424 | SCV000698490 | pathogenic | Xeroderma pigmentosum | 2017-04-06 | criteria provided, single submitter | clinical testing | Variant summary: The XPC c.2074A>T (p.Lys692*) variant results in a premature termination codon, predicted to cause a truncated or absent XPC protein due to nonsense mediated decay, which are commonly known mechanisms for disease. These predictions were confirmed by Khan et al (2006) who showed severely reduced level of mRNA and lack of protein expression in in vitro assay. This variant was found in 1/108904 control chromosomes at a frequency of 0.0000092, which does not exceed the estimated maximal expected allele frequency of a pathogenic XPC variant (0.0014142). This variant has been reported in at least two unrelated patients with Xeroderma Pigmentosum (Khan_2006, Kuschal_2013). In addition, truncation variants downstream of this position, such as c.2152C>T (p.R718*), c.2262delC (p.Asn754Lysfs) and c.2251-1G>C have been classified as "Pathogenic" by reputable databases/diagnostic laboratories . Taken together, this variant is classified as Pathogenic. |
Labcorp Genetics |
RCV001390105 | SCV001591727 | pathogenic | not provided | 2024-04-02 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Lys692*) in the XPC gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in XPC are known to be pathogenic (PMID: 23173980, 25256075). This variant is present in population databases (rs374117852, gnomAD 0.002%). This premature translational stop signal has been observed in individual(s) with xeroderma pigmentosum (PMID: 16081512). ClinVar contains an entry for this variant (Variation ID: 496267). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV000666668 | SCV004206998 | pathogenic | Xeroderma pigmentosum, group C | 2024-03-27 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000666668 | SCV000790997 | likely pathogenic | Xeroderma pigmentosum, group C | 2017-04-18 | no assertion criteria provided | clinical testing |